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Abstract 
Copyright 2020 Revitt-Mills and Robinson. The development of antibiotic resistance poses an increasing 
threat to global health. Understanding how resistance develops in bacteria is critical for the advancement 
of new strategies to combat antibiotic resistance. In the 1980s, it was discovered that certain antibiotics 
induce elevated rates of mutation in bacteria. From this, an "increased evolvability" hypothesis was 
proposed: antibiotic-induced mutagenesis increases the genetic diversity of bacterial populations, thereby 
increasing the rate at which bacteria develop antibiotic resistance. However, antibiotic-induced 
mutagenesis is one of multiple competing factors that act on bacterial populations exposed to 
antibiotics. Its relative importance in shaping evolutionary outcomes, including the development of 
antibiotic resistance, is likely to depend strongly on the conditions. Presently, there is no quantitative 
model that describes the relative contribution of antibiotic-induced mutagenesis to bacterial evolution. A 
far more complete understanding could be reached if we had access to technology that enabled us to 
study antibiotic-induced mutagenesis at the molecular-, cellular-, and population-levels simultaneously. 
Direct observations would, in principle, allow us to directly link molecular-level events with outcomes in 
individual cells and cell populations. In this review, we highlight microscopy studies which have allowed 
various aspects of antibiotic-induced mutagenesis to be directly visualized in individual cells for the first 
time. These studies have revealed new links between error-prone DNA polymerases and recombinational 
DNA repair, evidence of spatial regulation occurring during the SOS response, and enabled real-time 
readouts of mismatch and mutation rates. Further, we summarize the recent discovery of stochastic 
population fluctuations in cultures exposed to sub-inhibitory concentrations of bactericidal antibiotics and 
discuss the implications of this finding for the study of antibiotic-induced mutagenesis. The studies 
featured here demonstrate the potential of microscopy to provide direct observation of phenomena 
relevant to evolution under antibiotic-induced mutagenesis. 
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The development of antibiotic resistance poses an increasing threat to global health. 
Understanding how resistance develops in bacteria is critical for the advancement of new 
strategies to combat antibiotic resistance. In the 1980s, it was discovered that certain 
antibiotics induce elevated rates of mutation in bacteria. From this, an “increased 
evolvability” hypothesis was proposed: antibiotic-induced mutagenesis increases the 
genetic diversity of bacterial populations, thereby increasing the rate at which bacteria 
develop antibiotic resistance. However, antibiotic-induced mutagenesis is one of multiple 
competing factors that act on bacterial populations exposed to antibiotics. Its relative 
importance in shaping evolutionary outcomes, including the development of antibiotic 
resistance, is likely to depend strongly on the conditions. Presently, there is no quantitative 
model that describes the relative contribution of antibiotic-induced mutagenesis to bacterial 
evolution. A far more complete understanding could be reached if we had access to 
technology that enabled us to study antibiotic-induced mutagenesis at the molecular-, 
cellular-, and population-levels simultaneously. Direct observations would, in principle, 
allow us to directly link molecular-level events with outcomes in individual cells and cell 
populations. In this review, we highlight microscopy studies which have allowed various 
aspects of antibiotic-induced mutagenesis to be directly visualized in individual cells for 
the first time. These studies have revealed new links between error-prone DNA polymerases 
and recombinational DNA repair, evidence of spatial regulation occurring during the SOS 
response, and enabled real-time readouts of mismatch and mutation rates. Further, 
we summarize the recent discovery of stochastic population fluctuations in cultures 
exposed to sub-inhibitory concentrations of bactericidal antibiotics and discuss the 
implications of this finding for the study of antibiotic-induced mutagenesis. The studies 
featured here demonstrate the potential of microscopy to provide direct observation of 
phenomena relevant to evolution under antibiotic-induced mutagenesis.
Keywords: stress response, DNA damage, imaging, experimental evolution, recombination
ANTIBIOTIC-INDUCED MUTAGENESIS: FROM MOLECULES 
TO CELLS TO POPULATIONS
Mutation is one of the two major mechanisms for the development of antibiotic resistance in 
bacteria (Woodford and Ellington, 2007). In the laboratory, high-level resistance against most 
antibiotics can be  acquired by bacteria through the development of mutations (Woodford and 
Ellington, 2007). In clinically relevant bacterial pathogens, resistance to most antibiotics is 
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acquired through lateral gene transfer; however, mutational 
resistance dominates in some circumstances. Resistance against 
fluoroquinolones (Appelbaum and Hunter, 2000; Ruiz, 2003), 
rifampicin (Gillespie, 2002), oxazolidinones (Long and Vester, 
2012), fusidic acid (Nagaev et  al., 2001; Besier et  al., 2005), 
and streptomycin (Gillespie, 2002) frequently arises through 
mutation (Woodford and Ellington, 2007). Commonly these 
are “target-gene mutations,” in which the systems that are 
targeted by the antibiotic become altered in such a way that 
the antibiotic no longer binds to its target or is otherwise 
made ineffective. Another important class of mutations that 
occur commonly among clinical isolates is loss-of-function 
mutations in regulators that can lead to increased activity of 
associated multi-drug efflux pumps (Woodford and Ellington, 
2007). Interestingly, the causative agent of tuberculosis, 
Mycobacterium tuberculosis, appears to acquire antibiotic 
resistance exclusively through mutation, as opposed to lateral 
gene transfer (Gillespie, 2002).
In many cases, we  have a strong understanding of how 
particular mutations lead to an increase in resistance against 
a particular antibiotic (Woodford and Ellington, 2007). Much 
is known about the molecular mechanisms that generate 
mutations and the evolutionary dynamics that allow them to 
fix within bacterial populations (Andersson and Hughes, 2017). 
In the simplest scenario, mutations occur spontaneously, arising 
from errors made during DNA synthesis (Martinez and Baquero, 
2000). Mutants are present in the population prior to antibiotic 
exposure and are strongly selected for once the population is 
exposed (Martinez and Baquero, 2000). This spontaneous 
mutation model serves as the null hypothesis in any study 
seeking to uncover the origins of a particular antibiotic resistance 
mutation. It is known, however, that some antibiotics can 
induce higher mutation rates in bacteria (Mao et  al., 1997; 
Oliver et  al., 2000; Blazquez et  al., 2018). The role of induced 
mutagenesis in the evolution of antibiotic resistance remains 
a lively field of research (Blazquez et  al., 2018).
Exposure to antibiotics can elevate mutation rates in bacteria 
in two ways. Both mechanisms have demonstrated capacity 
to drive the development of antibiotic resistance in laboratory 
models (Cirz et  al., 2005; Pribis et  al., 2019). First, antibiotic 
exposure often leads to the selection of hypermutator phenotypes; 
cells that have developed constitutively high mutation rates 
(Mao et  al., 1997; Oliver et  al., 2000; Shaver et  al., 2002; 
Blazquez, 2003; Durao et  al., 2018). These usually arise from 
loss-of-function mutations in systems that normally help to 
maintain low mutation rates, such as mismatch repair enzymes 
or proofreading exonucleases (Miller et  al., 1999; Rodriguez-
Rojas et  al., 2013; Durao et  al., 2018). Second, exposure to 
antibiotics can induce elevated mutation rates directly, by 
promoting the activities of error-prone DNA repair systems 
or by temporarily down-regulating mismatch repair (Frisch 
et  al., 2010; Shee et  al., 2011a). It is this second class of 
phenomena, termed antibiotic-induced mutagenesis or transient 
hypermutation, that is the primary focus of this review.
Antibiotic-induced mutagenesis is most often linked to the 
SOS response; a transcriptional program that upregulates a 
set of genes (~40  in Escherichia coli), most of which have 
functions relevant to DNA damage (Blazquez et  al., 2018; 
Maslowska et al., 2019). Included in the SOS regulon are genes 
that encode error-prone DNA polymerases (Goodman and 
Woodgate, 2013; Joseph and Badrinarayanan, 2020). During 
the SOS response, error-prone polymerases increase the rate 
at which mutations appear in cells (Kuban et al., 2004; Hastings 
et  al., 2010; Blazquez et  al., 2018). In this way, antibiotic 
exposure begets mutagenesis. The observation of antibiotic-
induced mutagenesis led to the proposal of an “increased genetic 
diversity” hypothesis in the early 2000s: antibiotic-induced 
mutagenesis drives an increase in the genetic diversity of bacterial 
populations and thus speeds the development of mutational 
antibiotic resistance (Radman, 1999; Martinez and Baquero, 
2000; Rosenberg, 2001; Cirz et  al., 2005). Twenty years later, 
this idea remains an active field of study (Blazquez et al., 2018).
There is ample evidence that antibiotic-induced mutagenesis 
occurs. Much of this evidence has been reviewed in detail 
recently (Blazquez et  al., 2018). The primary question facing 
the field is: does it matter? Does the potential increase in 
mutation supply brought on by antibiotic-induced mutagenesis 
ever outweigh the loss of diversity brought on by the antibiotic 
killing the cells? To our knowledge, only one experimental 
evolution study has specifically investigated whether antibiotic-
induced mutagenesis can play a dominant role in the evolution 
of antibiotic resistance. This study, which monitored the de 
novo appearance of ciprofloxacin-resistance mutations in a 
mouse infection model strongly suggested that resistance was 
dependent on antibiotic-induced mutagenesis (Cirz et al., 2005). 
As detailed below, assessing the role of antibiotic-induced 
mutagenesis in evolution requires that the effects of an antibiotic 
on mutagenesis are experimentally isolated from its effects on 
cell survival. Currently, this is almost impossible to do in 
animal models and this ultimately limits the use of top-down 
approaches toward studying evolution under antibiotic-induced 
mutagenesis. At the other end of the spectrum, observations 
made at the level of individual cells and small populations of 
cells may provide sufficient insight to enable accurate computer 
modeling of events that are too complex to monitor directly. 
With enough data, collected under carefully controlled conditions, 
this offers a potential means to approach the antibiotic-induced 
mutagenesis problem from the bottom-up.
Antibiotic-induced mutagenesis will only influence evolutionary 
outcomes in situations where the bacterial cells remain alive 
long enough to produce new mutations. Thus, it is likely that 
it occurs infrequently under high antibiotic concentrations, 
where most cells die quickly. For this reason, antibiotic-induced 
mutagenesis is typically studied at antibiotic concentrations close 
to, but below, the minimum inhibitory concentration (MIC). 
The evolutionary dynamics at play within this near-MIC regime 
are more complex than those that occur at lethal concentrations 
of antibiotic (Figure 1). At concentrations near the MIC, selection 
for resistant variants will be  weaker than for concentrations 
above MIC, although it is important to note that many antibiotics 
remain selective at concentrations far below the MIC (Andersson 
and Hughes, 2014). Near to the MIC, population genetics will 
play a major role in determining evolutionary outcomes 
(Hughes and Andersson, 2017). Competition for resources 
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between variants (clonal interference) will play a large role 
in determining the population structure (Hughes and 
Andersson, 2017). Population size will also shape evolutionary 
outcomes – large populations tend to disfavor the selection 
of rare variants unless they are particularly advantageous 
(Hughes and Andersson, 2017). The relative rates of cell 
growth and cell death will also be  important (Coates et  al., 
2018). It is widely known that exposing cells to near-MIC 
concentrations of bactericidal antibiotics causes the population 
to grow at a diminished rate. However, it was only demonstrated 
recently that this occurs because a portion of the population 
undergoes stochastic cell death (Coates et  al., 2018). Thus, 
the population growth rate slows because the cell death rate 
approaches the cell growth rate, rather than all the cells 
simply growing at a slower rate. This phenomenon is depicted 
in Figure  1 and is expanded upon in a later section. At the 
same time that antibiotic-induced mutagenesis is acting to 
increase genetic diversity (i.e., number of unique mutants) 
within the population, cell death acts to reduce the size of 
the population. Evolutionary outcomes, including the likelihood 
of the population becoming antibiotic resistant, will depend 
strongly on the balance of these two parameters.
We propose that to better understand the role of antibiotic-
induced mutagenesis on the evolution of antibiotic-resistance 
mutations, we  need to be  able to measure its effects while 
simultaneously monitoring cell and population level behaviors. 
This is not achievable with conventional microbiology techniques 
(e.g., fluctuation analyses), which operate as end-point assays 
and have indirect read-outs.
In recent years, researchers have begun to explore microscopy 
as a means to obtain direct, real-time observations of individual 
cells, and even individual molecules within them. The purpose 
of the current review is to highlight studies in which microscopy 
has improved our understanding of either the molecular 
mechanisms underlying antibiotic-induced mutagenesis or cell- 
and population-level events that occur when bacteria are 
challenged with sub-inhibitory concentrations of antibiotics. 
Much of the microscopy work presented here has been conducted 
in E. coli, due to its prevalence as a laboratory model organism, 
and with fluoroquinolones because these drugs are strongly 
FIGURE 1 | Antibiotic-induced mutagenesis is one of many factors that influence genetic diversity in bacterial populations. Many antibiotics induce elevated rates 
of mutagenesis in bacterial cells. However, the relative importance of antibiotic-induced mutagenesis in shaping the evolution of antibiotic resistance remains unclear. 
This figure illustrates some of the competing factors that increase and decrease genetic diversity (i.e., number of unique mutants) in antibiotic-exposed bacteria. It is 
not intended to serve as a functional model of resistance development. An initial population of antibiotic-naïve cells appears in the center. The majority of cells in the 
population are of the major genotype (“wild type”; gray circles). Due to there being a basal rate of spontaneous mutagenesis, some cells have variant genotypes 
(colored circles). The left panels depict a scenario in which a lethal dose of bactericidal antibiotics is administered. Under these conditions, the rate of cell death 
outpaces the rate of cell division. In the first stage of this inhibitory concentration scenario, most of the population is killed (circles disappear). A few cells initially 
survive long enough to divide, however, in time these are also killed. Thus, no cells remain alive by the second stage of the scenario. Because there is little cell 
growth, there is little scope for antibiotic-induced mutagenesis. The genetic diversity of the population crashes as rapid cell death dominates over other factors. Any 
antibiotic-resistant mutants that are selected under these conditions are likely to be pre-existing in the population prior to antibiotic exposure. In the second 
scenario, depicted in the two right panels, a sub-inhibitory concentration of a bactericidal antibiotic is applied. As demonstrated recently (Coates et al., 2018), many 
cells die under these conditions, however, the rate of cell division outpaces the rate of cell death, leading to net population growth. In the first stage of this 
sub-inhibitory concentration scenario, a portion of cells die (~30%), while the remaining cells divide (~70%). Antibiotic-induced mutagenesis increases the probability 
that variants are produced during these cell divisions (gray circles more often yield colored circles). Specific examples of each event are depicted with arrows (i–iv; 
see example events legend). These processes of stochastic cell death, cell division, and mutagenesis are repeated in the second stage. Over time, the population 
becomes larger and contains a greater number of variants than the initial population. It is important to note, however, that the number of cell divisions required to 
reach a particular population size will be higher than what would be required in the absence of drug. Many experimental measures of induced mutagenesis rates 
neglect this behavior and will therefore be overestimated if cell death is occurring frequently (Frenoy and Bonhoeffer, 2018). Nevertheless, antibiotic-induced 
mutagenesis can significantly contribute to the development of antibiotic resistance in vivo (Cirz et al., 2005). Overall, the genetic diversity of the population in the 
sub-inhibitory concentration scenario will depend on the complex interplay between cell death, cell division, spontaneous mutagenesis, and induced mutagenesis. 
Selection for antibiotic-resistant phenotypes will occur at all stages and is likely to involve additional complexity arising from population-level phenomena that are not 
depicted in the figure.
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mutagenic and are commonly utilized as model compounds 
in laboratory experiments. For a more comprehensive review 
of antibiotic-induced mutagenesis, which includes work in other 
systems, we  suggest a recent review by Blazquez et  al. (2018). 
There remains tremendous scope to extend the studies highlighted 
within this review to other organisms and other antibiotics. 
While microscopy cannot resolve all of the gaps in knowledge 
that remain open in the field of antibiotic-induced mutagenesis, 
the studies highlighted in the current review demonstrate the 
potential for enormous gains to be  made. We  anticipate that 
the greatest impact of microscopy will be  in improving our 
understanding of how mutation rates are modulated in bacterial 
cells and in mapping mutations to fitness effects.
THE CELLULAR CONTEXT OF 
ANTIBIOTIC-INDUCED MUTAGENESIS
Before discussing the molecular mechanisms of antibiotic-induced 
mutagenesis, it is useful to consider the cellular context in which 
it takes place. Elevated mutagenesis is induced by several classical 
DNA-damaging agents, including UV light, mitomycin c, and 
methyl methanesulfonate (Maslowska et al., 2019). It is likely that 
all the antibiotics that induce mutagenesis do so by causing DNA 
damage. This can occur as a direct consequence of their mode 
of action (as is the case for fluoroquinolones, which inhibit type 
II-topoisomerases). Alternatively, DNA damage can occur indirectly, 
through errant metabolic processes that generate reactive-oxygen 
species (ROS; Kohanski et  al., 2010). In Figure  2, we  summarize 
some of the events known to take place in E. coli cells treated 
with ciprofloxacin, a fluoroquinolone antibiotic that is a key model 
compound in the study of antibiotic-induced mutagenesis (Cirz 
et  al., 2005; Zhang et  al., 2011; Bos et  al., 2015; Pribis et  al., 
2019). It is likely that much of what we  summarize for E. coli 
cells treated with ciprofloxacin extends to other organisms and 
to other antibiotics, although in most cases this remains to be tested.
Broadly speaking, E. coli cells respond to ciprofloxacin the 
same way they do to sub-inhibitory doses of other DNA damaging 
agents – they induce the SOS response (Pribis et  al., 2019). 
SOS induction has been measured directly for several 
fluoroquinolones (Ysern et  al., 1990; Thi et  al., 2011; Pribis 
et  al., 2019; Rodriguez-Rosado et  al., 2019), as well as for the 
antifolates trimethoprim and sulfamethoxazole (Thi et  al., 2011; 
Blazquez et al., 2012), and representative members of the β-lactams 
(Thi et al., 2011; Blazquez et al., 2012). Microscopy has revealed 
much about how E. coli cells respond to ciprofloxacin treatment. 
Once exposed, the cells continue to grow, but divide much less 
often, causing them to form long filaments (Figures 2A,B; Diver 
and Wise, 1986; Thi et  al., 2011; Bos et  al., 2015; Henrikus 
et al., 2018; Pribis et al., 2019). Bulk DNA replication continues 
during sub-inhibitory ciprofloxacin treatment (likely at a 
diminished rate; Goss et  al., 1965; Snyder and Drlica, 1979) 
and as a result the filamentous cells contain multiple nucleoid 
masses (Figure 2C; Bos et al., 2015). This suggests that filamentous 
cells contain multiple independent (or semi-independent) copies 
of the bacterial chromosome, although it is important to note 
that the masses are less organized than the nucleoids of untreated 
cells, and the study did not examine whether masses represent 
intact or partially degraded nucleoids.
Cells treated with ciprofloxacin contain elevated numbers of 
DNA double-strand breaks, which can be detected using fluorescent 
fusions of the Gam protein from bacteriophage λ (Figure  2D; 
Shee et  al., 2013; Pribis et  al., 2019). Detection of double-strand 
breaks through a fluorescent protein fusion of the RecN protein 
has also been reported (Hong et  al., 2017). It is likely that cells 
treated with other bactericidal compounds also contain large 
numbers of breaks as a consequence of having elevated ROS 
levels (Liu et  al., 2010; Foti et  al., 2012; Giroux et  al., 2017). 
We  have detected significant numbers of breaks appearing in 
cells treated with trimethoprim, for example (Henrikus et  al., 
2020). Double-strand breaks are important lesions for antibiotic-
induced mutagenesis for multiple reasons. First, double-strand 
breaks are considered to be  lethal to cells if left unrepaired 
(Cox, 2013). Second, the processing of double-strand breaks by 
the RecBCD helicase-nuclease complex is one of the major triggers 
for the induction of the SOS response in E. coli (Simmons et al., 
2008). This probably extends to other organisms such as Bacillus 
subtilis, that uses the functional analog of RecBCD, AddAB 
(Simmons et al., 2008). Third, much of the increased mutagenesis 
associated with ciprofloxacin treatment in E. coli can be attributed 
FIGURE 2 | Conditions inside bacterial cells undergoing antibiotic-induced 
mutagenesis. With the exception of panels (A) and (G), all panels depict 
Escherichia coli cells exposed to ciprofloxacin, a bactericidal antibiotic of the 
fluoroquinolones class. (A,B) E. coli growing as rod-shaped cells in the 
absence of antibiotics (A) and as filamentous cells in the presence of 
ciprofloxacin (B). Figure adapted from Diver and Wise (1986). (C) Filamentous 
E. coli cells contain multiple copies of the chromosome, as shown by DAPI 
staining. The number of chromosomes scales with filament length. 
Figure adapted from Bos et al. (2015). (D) Large numbers of DNA double-
strand breaks in ciprofloxacin-treated cells, as detected by a fluorescent protein 
fusion of the Gam protein. Figure adapted from Pribis et al. (2019). (E,F) 
Increased activity of fluorescently labeled error-prone DNA polymerases IV (E) 
and V (F) in ciprofloxacin-treated cells, as visualized by single-molecule 
fluorescence microscopy. Figures adapted from Henrikus et al. (2018, 2020). 
(G) Large bundle of fluorescently labeled RecA formed in an E. coli cell that 
contains a single DNA double-strand break induced via expression of the SceI 
restriction enzyme. Figure adapted from Lesterlin et al. (2014).  
(H) Colocalisation of error-prone DNA polymerase IV with RecA in ciprofloxacin-
treated cells. RecA-ssDNA nucleoprotein filaments (RecA*) are specifically 
visualized using a portion of the RecA*-binding cI repressor protein that has 
been fused to a fluorescent protein. Figure adapted from Henrikus et al. (2020).
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to a form of error-prone double-strand break repair (Pribis et al., 
2019). This activity requires error-prone DNA polymerases IV 
and V, induction of the SOS response (to produce sufficient 
amounts of these polymerases), and induction of the RpoS 
response (described in detail later), which plays a crucial, but 
unidentified role. Using single-molecule fluorescence microscopy, 
the activation of pols IV and V in cells exposed to ciprofloxacin 
has now been observed directly (Figures 2E,F and section below; 
Henrikus et  al., 2018). Fourth, homologous recombination is the 
primary mode of repair for double-strand breaks in E. coli 
(Dillingham and Kowalczykowski, 2008). The presence of multiple 
double-strand breaks in ciprofloxacin-treated cells (Figure  2D), 
together with the presence of multiple chromosome equivalents 
(Figure 2C), means that high levels of homologous recombination 
are likely to take place between chromosome equivalents. Inter-
chromosomal homologous recombination is thought to be mediated 
through the formation of large structures by the RecA protein 
(Figures 2G,H; Levin-Zaidman et al., 2000; Renzette et al., 2005; 
Lesterlin et  al., 2014; Ghodke et  al., 2019). Inter-chromosomal 
recombination has the potential to remove mutations, to introduce 
mutations (through error-prone break repair), and to combine 
mutations that originate within different chromosome variants 
into a single chromosome (Guttman and Dykhuizen, 1994; Lopez 
et  al., 2007; Lopez and Blazquez, 2009; Pribis et  al., 2019). In 
E. coli, inter-chromosomal recombination is strongly stimulated 
by exposure to ciprofloxacin (Lopez et  al., 2007; Lopez and 
Blazquez, 2009), but not by antibiotics outside of the 
fluoroquinolone class (Lopez and Blazquez, 2009).
While the phenomena described above provide valuable 
insight into events in cells that accompany antibiotic-induced 
mutagenesis, they are by no means the only factors involved. 
Environmental factors, including media composition, can 
dramatically impact mutagenesis (Maharjan and Ferenci, 2017). 
The intracellular production of ROS is demonstrated to 
be  important for mutagenesis induced by ciprofloxacin (Pribis 
et al., 2019; Rodriguez-Rosado et al., 2019) and is highly likely 
to be  involved in mutagenesis induced by other antibiotics 
(Kohanski et  al., 2010; Thi et  al., 2011). Interestingly, while 
ciprofloxacin-induced mutagenesis is largely ROS-dependent 
(Pribis et al., 2019; Rodriguez-Rosado et al., 2019), the mutation 
signatures produced do not match the expected signature for 
incorporation of 8-oxoguanine, an aberrant nucleotide that is 
highly mutagenic toward DNA replication in vitro and is known 
to accumulate in high ROS cells (Song et  al., 2016). This 
suggests that the primary contribution of ROS production 
toward ciprofloxacin-induced mutagenesis is the triggering of 
mutagenic DNA repair pathways, as opposed to mutagenesis 
that results directly from oxidation of the nucleotide pool.
MOLECULAR MECHANISMS OF 
ANTIBIOTIC-INDUCED MUTAGENESIS: 
ACTIVATION OF SOS AND 
ERROR-PRONE DNA POLYMERASES
The most widely studied form of antibiotic-induced 
mutagenesis is associated with the SOS response and involves 
increased production of error-prone DNA polymerases. E. coli 
produce three SOS-induced DNA polymerases (pols), pol II, 
pol IV, and pol V (Goodman and Woodgate, 2013). Of these, 
pols IV and V appear to be  most responsible for 
SOS-dependent antibiotic-induced mutagenesis, although 
pol II can contribute to mutagenesis in some circumstances 
(Cirz et  al., 2005; Pribis et  al., 2019).
Pol V is the most error-prone DNA pol produced in E. 
coli cells (Jaszczur et  al., 2016). Its activity is regulated at 
multiple levels, ensuring that its activity in the absence of 
exogenous DNA damage is minimal (Goodman et  al., 2016). 
At least three steps in the pol V regulation pathway are 
dependent on RecA* nucleoprotein filaments (multimeric 
filaments of RecA on single-stranded DNA), which are produced 
during the repair of single-stranded DNA gaps and double-
strand breaks via homologous recombination (Goodman et al., 
2016). First, pol V is assembled from the products of an 
SOS-regulated operon, umuDC (Tang et  al., 1999; Fernandez 
de Henestrosa et  al., 2000). Induction of the SOS response 
occurs when RecA* nucleoprotein filaments induce autocatalytic 
cleavage of the SOS repressor protein LexA (Maslowska et  al., 
2019). Thus, the UmuD2 (UmuD homodimer) and UmuC 
proteins are only expressed once RecA* accumulates in cells. 
At this stage, however, UmuD2 and UmuC do not form an 
active polymerase. Second, UmuD2 homodimers undergo 
autocatalytic cleavage in the presence of RecA*, in a mechanism 
analogous to that of LexA (Goodman et al., 2016). This cleavage 
produces the shorter protein UmuD'2. Whereas UmuD2 and 
UmuD'2 are relatively stable, the intermediate heterodimer form 
UmuDD' is rapidly degraded by the ClpXP protease, which 
imparts a form of threshold on the RecA*-mediated conversion 
of UmuD2 to UmuD'2 (Gonzalez et  al., 1998). Third, RecA* 
is again required to form the active version of pol V, known 
as pol V Mut. UmuD'2 and UmuC physically interact to form 
pol V; however, this complex is a very poor polymerase (note 
that in this context pol V specifically refers to the complex 
UmuD'2C; Goodman et  al., 2016). In a remarkable feat of 
biochemistry, pol V next locates a RecA* filament and extracts 
a single RecA protomer, with ATP intact, from the 3' proximal 
end (Goodman et al., 2016). This process forms the mutagenically 
active complex pol V Mut (UmuD'2C-RecA-ATP; Jiang et  al., 
2009). Once formed, pol V Mut remains active for only a few 
seconds before cleaving the ATP (via intrinsic ATPase activity; 
an unprecedented function among polymerases; Erdem et  al., 
2014; Jaszczur et al., 2019), at which point the complex becomes 
inactive (Goodman et  al., 2016).
Microscopy is already beginning to play a major role in 
improving our understanding of these polymerases in bacteria 
(Joseph and Badrinarayanan, 2020). Using single-molecule 
fluorescence microscopy, we  visualized the RecA*-dependent 
activation of pol V in cells treated with DNA damaging agents, 
including ciprofloxacin (Robinson et  al., 2015; Henrikus et  al., 
2020). In doing so, we  discovered yet another element that 
controls pol V activity – spatial regulation (Figure 3A; Robinson 
et  al., 2015). While spatial regulation has been well-established 
in eukaryotic systems, this was the first example of a DNA-acting 
enzyme being spatially regulated in bacteria. In the case of 
Revitt-Mills and Robinson AIM: Under the Microscope
Frontiers in Microbiology | www.frontiersin.org 6 October 2020 | Volume 11 | Article 585175
pol V, spatial regulation is imposed via an interaction between 
UmuC and the inner cell membrane. Following SOS-induced 
expression of UmuD2 and UmuC, but prior to UmuD′2 being 
formed, UmuC associates with the membrane. Once UmuD′2 
is formed, UmuC is released from the membrane as part of 
either pol V (UmuD′2C) or pol V Mut (UmuD′2C-RecA-ATP). 
It remains unknown whether pol V Mut formation occurs on 
the membrane or in the cytosol. In the microscopy images, 
pol V spatial regulation presents as a redistribution of 
fluorescently labeled UmuC from the membrane to the cytosol. 
Due to the fact that UmuC is expressed at very low levels in 
E. coli (0–15  mol/cell; Robinson et  al., 2015), UmuC produced 
patchy signals and this spatial redistribution was difficult to 
observe by eye, but was well-supported by statistical analyses. 
In subsequent work, we  developed a novel image-analysis 
technique that enabled us to extract the relative proportion 
of membrane-bound and cytosolic UmuC as a function of 
time (Goudsmits et  al., 2016). As UmuC levels peak, 90% of 
the protein is associated with the membrane. Within 30  min, 
this proportion decreases to 50%, with the remaining 50% 
now appearing in the cytosol. As pol V Mut is formed and 
begins to work on the DNA within the cytosol, punctate foci 
of UmuC are formed. This phenomenon is known as detection 
by localization and occurs because the rate of diffusional motion 
slows dramatically once the protein binds to the DNA. 
Interestingly, we  observed that pol V Mut foci formed at sites 
on the nucleoid that were spatially distinct from replisomes 




FIGURE 3 | Recent insights into the activities of error-prone DNA polymerases in bacterial cells. (A,B) Single-molecule fluorescence microscopy analysis of DNA 
polymerase V in E. coli cells carrying UV-induced DNA damage. Figures adapted from Robinson et al. (2015). (A) DNA polymerase V is a rare example of a spatially 
regulated polymerase enzyme in bacteria, with intermediate forms being localized to the cell membrane and only the fully activated form being allowed to redistribute 
into the cytosol. The active form of DNA polymerase V, pol V Mut, is comprised of two molecules of UmuD', one molecule of UmuC, one molecule of RecA, and one 
molecule of ATP (i.e., UmuD'2-UmuC-RecA-ATP; Jiang et al., 2009). The formation of pol V Mut is regulated at several levels, in order to minimize pol V-dependent 
mutagenesis in the absence of DNA damage (Goodman et al., 2016). All stages of pol V regulation involve activities of RecA* nucleoprotein filaments. A single-molecule 
fluorescence microscopy analysis of cells expressing a fluorescent protein fusion of UmuC (UmuC-mKate2), revealed three stages in the activation of pol V in cells 
treated with a burst of UV light (Robinson et al., 2015). In phase I, cells began to grow into filaments, indicating induction of the SOS response, but produced little 
UmuC-mKate2. In phase II, cells began to express UmuC-mKate2. In this phase, UmuC-mKate2 was localized to the cell membrane. Due to the small number of 
UmuC-mKate2 features present in each cell, this can be difficult to see in individual representative images, but becomes abundantly clear in statistical analyses of cells 
across multiple images. Membrane localization is most evident in the image labeled “peak intensity”, where clear membrane-associated signals are visible along the 
edge of the cell. Finally, in phase III, UmuC-mKate2 was released into the cytosol as pol V Mut, where it formed punctate foci on the nucleoid, indicative of DNA 
synthesis occurring. This can be seen most clearly in the image labeled “peak + 30 min”. Release of UmuC from the membrane requires the cleavage of the UmuD 
protein to its shorter form UmuD'. (B) Pol V Mut rarely colocalises with replisomes. Contrary to existing models of pol V-dependent DNA synthesis, in which pol V 
carries out translesion synthesis at stalled replication forks, single-molecule fluorescence imaging revealed that pol V Mut rarely colocalises with replication forks. This 
indicates that pol V likely works on other DNA substrates in cells, which may include single-stranded gaps and/or recombination intermediates. (C–E) DNA polymerase 
IV (pol IV) works on double-strand break repair intermediates in cells treated with ciprofloxacin. (C) Single-molecule fluorescence microscopy demonstrated that 
fluorescently labeled pol IV forms foci that colocalise with sites of double-strand breaks induced by the SceI restriction enzyme. Figure adapted from Mallik et al. (2015). 
(D) A second single-molecule imaging study demonstrated that the formation of pol IV foci in cells treated with either ciprofloxacin or trimethoprim requires processing 
of double-strand breaks by the RecBCD complex. Figure adapted from Henrikus et al. (2020). This, together with other evidence, indicates that these foci likely 
represent pol IV working on recombination intermediates during double-strand break repair. (E) Ciprofloxacin-induced mutagenesis is a form of error-prone double-
strand break repair, requiring induction of the SOS and RpoS responses (regulated by lexA and rpoS), double-strand break repair (dependent on recA, recB, recC, and 
ruvC), and error-prone DNA polymerases (Pols II, IV, and V). Figure adapted from Pribis et al. (2019). Crucially, the RpoS response is only induced in a sub-population 
of cells, indicating that ciprofloxacin-induced mutation rates are elevated within only a fraction of the cell population (~10%).
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non-replisomal substrates, such as single-stranded DNA gaps 
or homologous recombination intermediates (Robinson et  al., 
2015). In a follow-up study, we  observed that the number of 
pol V Mut foci formed in ciprofloxacin-treated cells did not 
appear to correlate with the number of double-strand breaks 
present, indicating that the substrates for pol V Mut are unlikely 
to be  homologous recombination intermediates formed during 
double-strand break repair (Henrikus et  al., 2020).
In contrast, recent studies have revealed a clear role in 
double-strand break repair for the other error-prone polymerase 
present in E. coli, pol IV. A role for pol IV in (error-prone) 
break repair was originally discovered through genetics 
experiments (Ponder et al., 2005). The single-molecule imaging 
measurements described below demonstrated that break-repair 
intermediates are the major substrates for pol IV in cells treated 
with (fluoro)quinolone antibiotics.
While many had tried, the Foster group was the first to 
produce a functional fluorescent protein fusion of pol IV (Mallik 
et  al., 2015). This was a considerable achievement as assaying 
for pol IV-dependent activities in cells is non-trivial. Furthermore, 
the activity of fusions turns out to be  highly sensitive to the 
length of the linker used to connect the pol IV protein (DinB) 
to the fluorescent protein. Using the active (20 amino-acid 
linker) fusion they showed, among other things, that pol IV 
localizes as punctate foci in cells treated with the quinolone 
antibiotic naladixic acid (Mallik et  al., 2015). These foci tightly 
colocalised with RecA* foci, which are expected to form at 
sites of double-strand breaks. Using a restriction enzyme to 
induce a single break within the chromosome, they observed 
that pol IV localized to the break site (Figure  3C). Building 
on this work, we  showed that the binding of pol IV to the 
nucleoid in cells treated with ciprofloxacin or trimethoprim 
was strongly dependent on a gene (recB) involved in double-
strand break repair (Henrikus et  al., 2020). Disruption of the 
RecBCD complex, which carries out the early stages of double-
strand break repair, almost completely abolished the formation 
of pol IV foci in cells treated with either ciprofloxacin or 
trimethoprim (Figure  3D). Together with existing evidence 
from genetics and biochemistry studies (Ponder et  al., 2005; 
Williams et  al., 2010; Shee et  al., 2011a,b, 2012; Pomerantz 
et  al., 2013a,b; Tashjian et  al., 2019), these microscopy 
observations indicated that a major role of pol IV in cells is 
to act in double-strand break repair. The likely function for 
pol IV in this context is the extension of D-loop structures.
Using a combination of microscopy and classical genetics 
approaches, the Rosenberg group recently demonstrated that 
ciprofloxacin-induced mutagenesis is ROS-dependent, and is 
driven by error-prone double-strand break repair (Pribis et  al., 
2019). Ciprofloxacin-induced mutagenesis was found to 
be  dependent on genes encoding pols II, IV, and V (polB, 
dinB, and umuDC), double-strand break repair factors (recA, 
recB, and ruvC), the SOS response (mutagenesis was blocked 
in a lexA [Ind−] background), and the RpoS response (Figure 3E; 
the RpoS response is introduced in greater detail in the next 
section). The authors discovered that ROS levels were elevated 
in a sub-population (~10%) of ciprofloxacin-treated cells. Elevated 
mutagenesis was strongly enriched within this sub-population. 
In this context, the main function of ROS is to induce the 
RpoS response; mild overexpression of RpoS alleviated the 
requirement for ROS in the mutagenesis assays. The observation 
of an RpoS-high sub-population is an example of phenotypic 
heterogeneity. Microscopy is revealing phenotypic heterogeneity 
to be  a common theme bacterial DNA repair and mutagenesis 
(Vincent and Uphoff, 2020). Improving our understanding of 
population heterogeneities is vital if we are to better understand 
antibiotic-induced mutagenesis.
Whereas, the Rosenberg study points to pol IV-dependent 
error-prone break repair occurring in a subset of high-ROS, 
RpoS-positive cells (Pribis et  al., 2019), our imaging study 
showed that ciprofloxacin-induced pol IV foci formed in all 
cells (Henrikus et  al., 2020). The model that is most consistent 
with the data is that pol IV is involved in double-strand break 
repair in all cells and that this somehow becomes error-prone 
in the RpoS-positive sub-population. In other words, the RpoS 
response modulates the fidelity of pol IV, rather than its ability 
to engage double-strand break repair intermediates. The role 
of RpoS in mutagenesis remains unknown, however, it is 
tempting to speculate that RpoS-dependent modulation of 
mismatch repair could play a role, as has been reported in 
other systems (Gutierrez et  al., 2013).
MOLECULAR MECHANISMS OF 
ANTIBIOTIC-INDUCED MUTAGENESIS: 
RpoS RESPONSE AND REGULATION OF 
MISMATCH REPAIR
Using classical genetics approaches, the Matic group discovered 
that cells treated with the β-lactam antibiotic ampicillin induced 
pol IV-dependent mutagenesis (Gutierrez et al., 2013). As with 
the ciprofloxacin-induced mutagenesis (Pribis et  al., 2019) 
described in the previous section, the RpoS response was found 
to play a key role in ampicillin-induced mutagenesis (Gutierrez 
et al., 2013). The RpoS response (also known as the σS response 
or general stress response) is induced under a variety of 
circumstances, including stationary growth, starvation, and 
oxidative damage (Battesti et  al., 2011; Gottesman, 2019). The 
protein RpoS (or σS) is an alternative σ-factor that governs 
the expression of hundreds of different genes (Battesti et  al., 
2011). When expressed, RpoS competes with the housekeeping 
σ-factor, σ70 (or RpoD), for binding to RNA polymerase, and 
in doing so dramatically changes the gene expression profile 
of the cell (Battesti et  al., 2011).
The Matic group showed that representative quinolone, 
β-lactam, and aminoglycoside antibiotics induced the RpoS 
response (Gutierrez et  al., 2013). Choosing to investigate 
ampicillin in greater depth, they demonstrated that ampicillin-
induced mutagenesis required both pol IV and induction of 
the RpoS response. Unlike ciprofloxacin-induced mutagenesis, 
induction of the SOS response was not required for ampicillin-
induced mutagenesis. They also observed that mild overexpression 
of the mismatch repair protein MutS (which functions to 
recognize nucleotide mismatches) completely suppressed 
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FIGURE 4 | Direct detection of mismatches in E. coli cells treated with norfloxacin. (A,B) A single-molecule fluorescence microscopy study of cells growing in 
microfluidic chemostats revealed an increased rate of mismatches in cells treated with the fluoroquinolone antibiotic norfloxacin. Figures adapted from Uphoff (2018). 
(A) A microfluidic “mother machine” was used to monitor individual cells through multiple generations. A fluorescent protein fusion of the mismatch repair protein 
MutL (MutL-mYPet) allowed mismatches to be visualized as punctate foci within cells. (B) Treatment of cells with norfloxacin induces a substantial increase in 
mismatch rate. Left unrepaired, these mismatches would become mutations during the subsequent round of DNA replication. The dynamics of mismatch formation 
match well with induction of the SOS response, which is monitored in this study by expression of cyan fluorescent protein (CFP) from the SOS-inducible dinB 
promoter (pDinB-CFP). Importantly, both SOS induction and the elevated mismatch rate lag behind cell death – increased mutagenesis is likely to occur in a small 
number of cells that survive beyond the initial stages of treatment.
mutagenesis. This led to the discovery of a small regulatory 
RNA, SdsR, which is expressed during the RpoS response and 
reduces the expression of MutS. They proposed a model in 
which depletion of mismatch repair leads to less efficient repair 
of mismatches produced by pol IV, which in turn leads to 
increased mutagenesis.
Representative quinolones and aminoglycosides also induce 
the RpoS response (Gutierrez et  al., 2013) and exhibit pol 
IV-dependent mutagenesis (Thi et  al., 2011). It is reasonable 
to speculate that the depletion-of-mismatch-repair mechanism 
at play during ampicillin-induced mutagenesis may extend to 
other bactericidal antibiotics. A single-molecule/single-cell 
imaging approach that would seemingly provide the ideal 
platform on which to test this idea has already been developed.
Elez developed an approach that allowed mismatches to 
be visualized by microscopy (Elez et al., 2012). By fluorescently 
labeling the mismatch repair protein MutL (the molecular 
coordinator of mismatch repair), it became possible to visualize 
the process of mismatch detection by the MutS and MutL 
proteins. Each time a mismatch was detected, a punctate MutL 
focus became visible in microscope images. In a series of later 
studies, Elez and colleagues repeated the measurements in cells 
that lacked the mutH gene, which is required for repair of 
the mismatch (Elez et  al., 2010, 2018; Robert et  al., 2018). 
This ensured that the mismatch would be  fixed to a mutation 
in the next round of DNA replication, providing a means to 
infer mutation rates in real-time.
While it was not the primary goal his study 
(Uphoff, 2018), Stephan Uphoff used the labeled-MutL system 
to study mismatch-detection rates in cells treated with the 
fluoroquinolone antibiotic norfloxacin (Figure  4). Growing 
the cells in a single-cell chemostat device called a “mother 
machine” (Figure  4A; Wang et  al., 2010), he  observed a 
significant increase in the number of mismatches detected 
in cells by fluorescent MutL (Uphoff, 2018). Delivering a 
pulse of norfloxacin at a concentration equal to the MIC, 
a transient 5-fold increase in the number of detected 
mismatches was observed (Figure  4B). Delivering a lower 
concentration (0.25x MIC) for a longer time led to a more 
sustained elevation (3-fold) of the mismatch-detection rate. 
In both experiments, induction of the SOS was also measured, 
revealing that changes in the mismatch-detection rate correlated 
with induction of the SOS response. The MutL-based mismatch-
detection system could be  an extremely useful tool in the 
study of antibiotic-induced mutagenesis. In particular, it would 
allow the role of RpoS-based regulation of mismatch repair 
to be  assessed much more broadly and at an unprecedented 
level of detail. Each MutL focus represents a mismatch that 
would normally be  repaired before becoming fixed as a 
mutation. One would hypothesize that disruption of the RpoS 
response would prevent the down-regulation of MutS, leading 
to more efficient detection of mismatches and a corresponding 
increase in the number of MutL foci detected in cells treated 
with antibiotics.
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MEASUREMENTS LINKING MUTATIONS 
TO CELL AND POPULATION 
OUTCOMES
The mismatch-detection approach developed by Elez would also 
be  an ideal platform to begin connecting the molecular world 
of mutagenesis with changes at the cell and population levels. 
In fact, her group has already taken steps in this direction, 
measuring a key population-level descriptor, the distribution 
of fitness effects, and for cells growing in microfluidic mother 
machines (Robert et  al., 2018). These devices allow for long-
term measurements to be  made under precisely controlled 
experimental conditions. The group monitored mismatch detection 
by MutL in a mismatch repair-defective mutH strain so that 
mismatches would be  fixed as mutations in subsequent round 
of DNA replication (Figure  5A). In parallel, they tracked cell 
growth rates, enabling them to link the appearance of spontaneous 
mutations in cells with changes in growth rate. Because the 
cells were physically isolated from each other within the mother 
machine, there was no competition between variants in the 
population and thus, growth rate measurements directly reflected 
the fitness of the mutants in the conditions tested. Approximately, 
~20,000 individual mutation events were detected over 200 
generations. The measurements revealed that the majority of 
mutations observed in this experiment were quasi-neutral, having 
little, or no effect on fitness. Only 1% of mutations were lethal.
Accurately measured distributions of fitness effects are key to 
evolutionary modeling and would be  particularly advantageous 
in the modeling of antibiotic-resistance development. If the mother 
machine format could be  adapted for use with antibiotics, this 
might even represent a route toward a quantitative assessment 
of the role of antibiotic-induced mutagenesis in the evolution of 
antibiotic resistance. Because the technique is based on microscopy, 
multiple facets of antibiotic-induced mutagenesis could 
be  monitored in parallel. In addition to mismatch rates and cell 
growth rates, cell filamentation and cell death could also 
be monitored. With appropriate probes already in hand, it should 
be  also possible to observe induction of the SOS and RpoS 
responses and corresponding activities of error-prone pols IV and V.
What might evolution to antibiotic resistance look like under 
the microscope? A 2015 study by Bos et  al. (2015) provides 
some clues. As highlighted earlier (Figure  2), the authors 
observed that cells treated with ciprofloxacin at 0.125x MIC 
grow into filaments that contain multiple nucleoid masses (Bos 
et  al., 2015). Occasionally, the authors observed regular-sized 
cells budding from the tip of these filaments (Figure  5B). 
Most of the time these buds were inviable, however, buds 
were occasionally produced that grew normally. These cells 
did not grow into filaments, indicating that they had become 
resistant to the antibiotic. Expansion of these resistant variants 
at 0.5x MIC or 1x MIC ciprofloxacin, followed by sequencing 
of the gyrA and marR loci, confirmed the presence of resistance 
mutations in many of the variants (in other cases, resistance 
was assumed to occur via mutations at other loci that were 
not sequenced). Expansion at 1x MIC strongly favored the 
gyrA (S83A) mutation, which appeared in 7/8 isolates. The 
Bos et al. (2015) study indicates that antibiotic-resistant variants 
can appear frequently enough to be  detected via microscopy.
MEASUREMENTS LINKING CELL 
GROWTH DYNAMICS TO POPULATION 
OUTCOMES
Antibiotics can induce mutagenesis, tolerance, and cell death. 
Evolution to antibiotic resistance is often limited by the mutation 
supply rate, which is a product of the cellular mutation rate 
and the size of the population (Hughes and Andersson, 2017). 
Elevated mutagenesis acts to increase the mutation supply, 
while cell death reduces it by decreasing the size of the 
population. Seeking to minimize the effects of cell death, 
antibiotic-induced mutagenesis is typically studied using sub-MIC 
concentrations of antibiotic. Importantly, it was demonstrated 
recently that significant cell death still occurs in this sub-MIC 
regime. Through a combination of microscopy, plate-reader 
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FIGURE 5 | Microscopy measurements linking mutations with phenotypic 
changes. (A) Direct measurement of a distribution of fitness effects from 
E. coli cells growing in a microfluidic chemostat. Figure adapted from 
Robert et al. (2018). Mismatches were detected using a fluorescent protein 
fusion of the mismatch repair protein MutL (YFP-MutL). Foci were produced in 
cells whenever YFP-MutL bound to a mismatch. The cells also carried a 
deletion of the mutH mismatch repair gene, ensuring that all mismatches 
became mutations in the subsequent round of DNA replication. The 
experimenters were able to link the appearance of mutations with changes in 
cell growth rates. They were able to produce a well-sampled distribution of 
fitness effects. Contrary to the dogma that most mutations are deleterious, 
the distribution showed that the vast mutations were quasi-neutral, having 
very little effect on growth. Only 1% of mutations were lethal. (B) Time-lapse 
microscopy captures the moment a ciprofloxacin-resistant cell buds from 
filamentous, multinucleate E. coli cell growing in a sub-inhibitory concentration 
of ciprofloxacin. Figure adapted from Bos et al. (2015).
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assays, and modeling, the Kim group investigated the extinction 
of small populations of cells (<100) upon treatment with 
antibiotics (Coates et  al., 2018). Their analysis revealed that 
bactericidal antibiotics induced stochastic fluctuations in 
population size. This was visualized by time-lapse microscopy 
images of cells growing in the presence of the cephalosporin 
antibiotic cefsulodin, at a concentration equivalent to 0.8x MIC 
(Figure  6). During the course of the time-lapse measurement, 
the total number of cells that are present increases, however, 
this occurs more slowly than in the absence of drug because 
many of the cells die. Stochastic cell death leads to marked 
fluctuations in the population size as a function of time. This 
simple observation has broad ramifications for the study of 
antibiotic-induced mutagenesis.
The fact that population growth in this near-MIC regime is 
the product of both cell growth and cell death means that 
many more generations are required for the population to reach 
a certain size than would be  required in the absence of drug. 
When rates of antibiotic-induced mutagenesis are measured using 
fluctuation analyses, the results are reported in units of mutations 
per genome per generation. Typically, the number of generations 
is calculated based on the population size after treatment, under 
the assumption that cells are not dying when the antibiotic 
concentration is below the MIC. In light of the stochastic 
population dynamics reported by the Kim group, it appears 
that many of the mutation rates reported in the literature may 
be  overestimated because more generations occurred than were 
accounted for in the measurements (Frenoy and Bonhoeffer, 2018).
The second important ramification of stochastic population 
dynamics for the study of antibiotic-induced mutagenesis is that 
when the population size is small, as would be  the case in a 
mother machine for example; many populations will become extinct 
when exposed to sub-MIC concentrations of bactericidal antibiotics. 
Evidence of this is visible in Uphoff ’s work with sub-MIC 
norfloxacin (Uphoff, 2018), where the number of viable cells 
decreases continuously throughout the experiment (Figure 4B). 
Presumably, this has occurred because of the small and finite 
size of the channels in the mother machine. Cells that are 
growing do not increase the size of the population being 
monitored because cells that no longer fit in the channel are 
washed away and thus are no longer monitored. Cells that 
die decrease the size of the observed population. Eventually, 
none of the channels would contain any viable cells. All of 
this occurred more quickly in cells treated with norfloxacin 
concentrations equivalent to the MIC because cells die more 
often. Because Uphoff monitored mismatch formation and cell 
death simultaneously we  can carry out a putative assessment 
of the effects of norfloxacin exposure on mutation supply. In 
measurements with 1x MIC norfloxacin, mismatch-detection 
rates increased while cell viability fell (Figure 4B). At its peak, 
mismatch-detection rates were ~5x above basal levels (Figure 4B; 
lower left panel; three generation times). At this time point, 
however, survival had dropped to 10% of the original value 
(Figure 4B; upper left panel; three generation times). If we take 
the product of these two values as a crude approximation of 
the mutation supply rate within the mother machine device, 
mutation supply would have fallen by 50% in the norfloxacin-
exposed population. In the measurements with 0.25x MIC 
norfloxacin, cell viability decreased more slowly (Figure  4B; 
upper right panel). By the five generations time-point, viability 
had reduced to 50% (Figure  4B; upper right panel), while 
the mismatch-detection rate had increased ~2.5x (Figure  4B; 
lower right panel). Thus, the mutation supply at this time 
would be predicted to be higher (125%) than that of the initial 
population. At a later time-point (eight generation times), the 
mutation supply would have been lower than the starting 
population; the mismatch-detection frequency had increased 
3x, however, cell survival was only ~15%. The effects of cell 
death are amplified in the mother machine format, however, 
the fact that mismatch-detection frequencies and cell survival 
rates change as a function of time after drug exposure highlight 
the need for simultaneous, real-time measurements of mutation 
rates, and cell growth/death parameters. Such measurements 
are vital if we  are to improve our understanding of antibiotic-
induced mutagenesis. Bacterial population sizes are also affected 
by non-genetic phenomena, such as antibiotic tolerance and 
persistence. Accurate measurements of cell growth and survival 
would also provide new opportunities to assess the roles of 
antibiotic tolerance and persistence in the development of 
antibiotic resistance mutations.
CONCLUDING REMARKS
The studies highlighted throughout this review demonstrate 
the potential of microscopy in helping to achieve a more 
thorough understanding of antibiotic-induced mutagenesis. 
There is enormous potential for other types of correlative 
measurements as well. Microscopy shows a great degree of 
promise as an important platform for uncovering functional 
FIGURE 6 | Antibiotic-induced population fluctuations. It is well known that 
when bacterial growth is monitored as a function of antibiotic concentration, 
population growth rates tend to slow as the minimum inhibitory concentration 
(MIC) is approached. Recently, it was discovered that for bactericidal 
antibiotics this reduction in the net growth of the population is caused not by 
the slowing of cell division, but by some of the cells dying (Coates et al., 2018). 
As the MIC is approached, the rate of cell death approaches that of cell 
division. This is neatly visualized by a time-lapse movie, which shows cells 
undergoing stochastic cell death when growing at a concentration of 
cefsulodin equivalent to 0.8x MIC. Live and dead cells can be distinguished by 
contrast. The live cells produce high contrast in the bright-field images, 
whereas the dead cells, which have lysed and have left behind an empty cell-
shaped sac, produce only low image contrast. At various points in the movie, 
a portion of the population undergoes stochastic cell death. These population 
fluctuations have far-reaching implications for the study of antibiotic-induced 
mutagenesis and for its potential to supply antibiotic resistance mutations. 
Figure adapted from Coates et al. (2018).
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linkages between the molecular-level actions of error-prone 
DNA repair processes, the cell-level behaviors of stress responses 
and growth dynamics, and population-level behaviors that 
determine mutation supply rates. The development of advanced 
techniques for microscopy and microfluidic technology is sure 
to continue, however, we  feel it is important to point out that 
great strides can be  taken with the technology that is already 
available. As has been noted previously (Potvin-Trottier et  al., 
2018), our understanding of other antibiotic-induced phenomena, 
including tolerance and persistence, would also strongly benefit 
from further application of state-of-the-art microscopy and 
microfluidic technologies.
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